APA (7th ed.) Citation

Schott, E., Ebert, M., & Trojanek, J. B. (2012). Treatment of hepatocellular carcinoma with sorafenib: Focus on special populations and adverse event. Zeitschrift für Gastroenterologie, 50(9), . https://doi.org/10.1055/s-0032-1312771

Chicago Style (17th ed.) Citation

Schott, Eckart, Matthias Ebert, and Joanna B. Trojanek. "Treatment of Hepatocellular Carcinoma with Sorafenib: Focus on Special Populations and Adverse Event." Zeitschrift Für Gastroenterologie 50, no. 9 (2012). https://doi.org/10.1055/s-0032-1312771.

MLA (9th ed.) Citation

Schott, Eckart, et al. "Treatment of Hepatocellular Carcinoma with Sorafenib: Focus on Special Populations and Adverse Event." Zeitschrift Für Gastroenterologie, vol. 50, no. 9, 2012, https://doi.org/10.1055/s-0032-1312771.